12 votes

Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates

1 comment

  1. JCPhoenix
    Link

    A panel of advisers to the Food and Drug Administration voted 10-1 against the overall benefits of MDMA when used to treat post-traumatic stress disorder. They cited flawed study data, questionable research conduct and significant drug risks, including the potential for heart problems, injury and abuse.

    9 votes